Recently, our in-house-produced mouse mAb MT99/3, which specifically targets the CD99 molecule, demonstrated the ability to induce apoptosis in T lymphoblastic leukemia/lymphoma (T-ALL/T-LBL) cells without causing cytotoxicity to non-malignant peripheral blood cells [14]. This evidence concerns the gene CD99 and acute lymphoblastic leukemia.